Related Experiment Video
Updated: Aug 12, 2026
A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
Published on: October 14, 2016
[Establishing a registry of malignant hemopathies in Côte-d'Or. Preliminary results]
Insights
A specialized registry in Côte-d'Or tracked malignant hematological diseases from 1980-1981. The study found higher incidence rates in men, highlighting the value of focused disease registries.
Area of Science:
- Hematology
- Epidemiology
- Public Health
Context:
- Established in 1980, a registry in Côte-d'Or aimed to assess malignant hematological diseases.
- Data was gathered from multiple sources including laboratories, hospitals, and death certificates.
Purpose:
- To determine the incidence and epidemiological features of malignant hematological diseases in Côte-d'Or.
- To compare incidence rates with other French registries and international data.
Summary:
- 194 new cases of acute leukemia, proliferative diseases, lymphomas, and myelodysplastic syndromes were recorded in 1980-1981.
- Crude incidence rates were 25.0/100,000 for men and 16.1/100,000 for women (Sex ratio: 1.5).
- Incidence in Côte-d'Or was higher than other French registries, comparable to Geneva and Connecticut.
Impact:
- Demonstrates the effectiveness of specialized registries in capturing disease incidence.
- Provides valuable epidemiological data for malignant hematological diseases in a specific French department.
- Offers a benchmark for comparison with national and international hematological disease registries.
Abstract:
A registry of malignant haematological diseases was established on January 1st 1980 in order to assess the incidence and epidemiologic features of these diseases in the department of Côte-d'Or (population 470 000). Information was collected from various sources (public or private laboratories, public or private hospitals and death certificates). During the course of two years (1980 and 1981) 194 news cases were recorded. This registry collects acute leukaemia, lymphoid and myeloid proliferative diseases, lymphomas in leukaemic phase and myelodysplastic syndromes. The crude incidence rates were 25.0/100,000 in men and 16.1/100,000 in women. Sex ratio : 1.5. Compared to other French population based registries the incidence is higher in Côte-d'Or, showing the value of specialised registries. The rates are similar to those reported in Geneva and Connecticut.
